Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Charles River Laboratories International leads the 115 health care companies ranked by P/E ratio, at 359, ahead of Takeda Pharmaceutical (306) and Waters (192). Figures as of 19 Nov 2026, 18:33 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- First
- Charles River Laboratories International359
- Median
- 30.3
- Combined market value
- NOK 87.42T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Charles River Laboratories InternationalCRL · Health Care | 359 | NOK 154.6B | NOK 3,227.13 | 0.78% down | 106% up | ||
| 2 | Takeda PharmaceuticalTAK · Health Care | 306 | NOK 667.7B | NOK 209.00 | 0.68% up | 51% up | ||
| 3 | WatersWAT · Health Care | 192 | NOK 881.9B | NOK 4,487.04 | 1.36% down | 23% up | ||
| 4 | Merck & CoMRK · Health Care | 134 | NOK 3.2T | NOK 1,296.75 | 3.56% down | 45% up | ||
| 5 | Ligand PharmaceuticalsLGND · Health Care | 117 | NOK 56.7B | NOK 2,833.77 | 2.80% down | 50% up | ||
| 6 | BiogenBIIB · Health Care | 107 | NOK 356.4B | NOK 2,411.28 | 1.73% down | 49% up | ||
| 7 | BillionToOneBLLN · Health Care | 100 | NOK 42.9B | NOK 898.85 | 0.61% up | 4% down | ||
| 8 | TG TherapeuticsTGTX · Health Care | 97.8 | NOK 96.7B | NOK 639.44 | 0.91% down | 117% up | ||
| 9 | SolventumSOLV · Health Care | 95.8 | NOK 141.4B | NOK 832.15 | 1.40% down | 9% up | ||
| 10 | Teva Pharmaceutical IndustriesTEVA · Health Care | 91.4 | NOK 447.6B | NOK 383.65 | 6.91% down | 74% up | ||
| 11 | MedlineMDLN · Health Care | 85.6 | NOK 483.9B | NOK 367.74 | 3.78% down | 4% down | ||
| 12 | TeleflexTFX · Health Care | 81.0 | NOK 63.7B | NOK 1,605.25 | 0.83% down | 58% up | ||
| 13 | PenumbraPEN · Health Care | 80.7 | NOK 123.2B | NOK 3,124.90 | 0.13% down | 15% up | ||
| 14 | ICONICLR · Health Care | 76.9 | NOK 140.5B | NOK 1,875.49 | 1.53% down | 23% up | ||
| 15 | LifeStance Health GroupLFST · Health Care | 74.1 | NOK 49.5B | NOK 130.24 | 3.09% down | 123% up | ||
| 16 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 71.8 | NOK 72.6B | NOK 924.62 | 0.33% down | 129% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | 70.7 | NOK 149.6B | NOK 2,331.35 | 3.59% down | 41% up | ||
| 18 | RevvityRVTY · Health Care | 68.0 | NOK 166.6B | NOK 1,492.62 | 0.33% up | 62% up | ||
| 19 | HeartflowHTFL · Health Care | 67.7 | NOK 38.9B | NOK 442.50 | 1.20% down | 66% up | ||
| 20 | Bio-TechneTECH · Health Care | 66.7 | NOK 111.5B | NOK 709.66 | 0.05% down | 24% up | ||
| 21 | Edwards LifesciencesEW · Health Care | 60.5 | NOK 584.3B | NOK 1,016.21 | 1.05% down | 25% up | ||
| 22 | IncyteINCY · Health Care | 59.3 | NOK 231.1B | NOK 1,133.67 | 1.39% down | 16% up | ||
| 23 | AlconALC · Health Care | 54.9 | NOK 352.9B | NOK 734.70 | 0.03% up | 0% up | ||
| 24 | Amneal PharmaceuticalsAMRX · Health Care | 53.5 | NOK 72.8B | NOK 208.85 | 2.19% down | 90% up | ||
| 25 | HaemoneticsHAE · Health Care | 53.0 | NOK 53.3B | NOK 1,169.58 | 2.46% down | 64% up | ||
| 26 | BeOne MedicinesONC · Health Care | 51.6 | NOK 448.6B | NOK 3,927.13 | 0.30% down | 16% up | ||
| 27 | Intuitive SurgicalISRG · Health Care | 49.8 | NOK 1.39T | NOK 4,022.09 | 2.10% down | 24% down | ||
| 28 | Corcept TherapeuticsCORT · Health Care | 48.8 | NOK 69.4B | NOK 633.88 | 4.19% down | 10% down | ||
| 29 | AbbVieABBV · Health Care | 48.7 | NOK 4.89T | NOK 2,763.86 | 0.98% down | 25% up | ||
| 30 | IDEXX LaboratoriesIDXX · Health Care | 46.5 | NOK 530.6B | NOK 6,735.00 | 1.20% down | 1% up | ||
| 31 | BrightSpring Health ServicesBTSG · Health Care | 46.0 | NOK 126.1B | NOK 633.49 | 5.02% down | 109% up | ||
| 32 | Royalty PharmaRPRX · Health Care | 44.5 | NOK 382B | NOK 664.43 | 0.86% down | 79% up | ||
| 33 | West Pharmaceutical ServicesWST · Health Care | 44.2 | NOK 267.6B | NOK 3,841.25 | 2.58% down | 57% up | ||
| 34 | GenmabGMAB · Health Care | 44.1 | NOK 310.6B | NOK 503.74 | 1.27% up | 70% up | ||
| 35 | Eli LillyLLY · Health Care | 44.0 | NOK 11.79T | NOK 13,234.05 | 1.93% down | 33% up | ||
| 36 | Krystal BiotechKRYS · Health Care | 43.0 | NOK 91.6B | NOK 3,091.52 | 0.45% up | 54% up | ||
| 37 | Becton, DickinsonBDX · Health Care | 42.1 | NOK 566.4B | NOK 2,079.56 | 1.39% down | 45% up | ||
| 38 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.4 | NOK 121.2B | NOK 145.42 | 0.53% down | 8% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | 40.5 | NOK 6.28T | NOK 2,607.57 | 2.02% down | 34% up | ||
| 40 | PfizerPFE · Health Care | 39.5 | NOK 1.54T | NOK 270.14 | 1.35% down | 15% up | ||
| 41 | Abbott LaboratoriesABT · Health Care | 38.9 | NOK 1.76T | NOK 1,016.75 | 0.29% down | 16% down | ||
| 42 | DanaherDHR · Health Care | 37.6 | NOK 1.56T | NOK 2,218.73 | 0.54% down | 3% up | ||
| 43 | HumanaHUM · Health Care | 37.2 | NOK 446.5B | NOK 3,717.35 | 1.27% down | 73% up | ||
| 44 | Mettler-Toledo InternationalMTD · Health Care | 37.0 | NOK 330.7B | NOK 16,623.78 | 1.95% down | 24% up | ||
| 45 | Thermo Fisher ScientificTMO · Health Care | 36.4 | NOK 2.5T | NOK 6,739.63 | 0.31% down | 21% up | ||
| 46 | Cardinal HealthCAH · Health Care | 35.5 | NOK 618.6B | NOK 2,676.55 | 1.46% down | 34% up | ||
| 47 | Medpace HoldingsMEDP · Health Care | 35.3 | NOK 173.6B | NOK 6,205.69 | 1.70% down | 10% up | ||
| 48 | IlluminaILMN · Health Care | 35.0 | NOK 300B | NOK 1,984.31 | 3.19% down | 76% up | ||
| 49 | HealthEquityHQY · Health Care | 34.9 | NOK 78B | NOK 942.57 | 0.75% down | 3% down | ||
| 50 | Agilent TechnologiesA · Health Care | 34.7 | NOK 484.8B | NOK 1,719.33 | 0.65% down | 22% up | ||
| 51 | Vertex PharmaceuticalsVRTX · Health Care | 33.7 | NOK 1.3T | NOK 5,114.33 | 2.31% down | 27% up | ||
| 52 | StrykerSYK · Health Care | 33.6 | NOK 1.17T | NOK 3,075.32 | 0.96% down | 12% down | ||
| 53 | argenxARGX · Health Care | 32.7 | NOK 578.6B | NOK 9,201.28 | 0.16% up | 2% up | ||
| 54 | Merit Medical SystemsMMSI · Health Care | 31.8 | NOK 49.6B | NOK 828.10 | 1.26% down | 1% up | ||
| 55 | DexComDXCM · Health Care | 31.5 | NOK 291.3B | NOK 781.01 | 3.02% down | 41% up | ||
| 56 | IQVIA HoldingsIQV · Health Care | 30.8 | NOK 406.7B | NOK 2,467.60 | 1.94% down | 19% up | ||
| 57 | STERISSTE · Health Care | 30.3 | NOK 242B | NOK 2,492.48 | 1.61% down | 1% up | ||
| 58 | AvantorAVTR · Health Care | 30.3 | NOK 100.1B | NOK 147.66 | 1.56% down | 40% up | ||
| 59 | Labcorp HoldingsLH · Health Care | 30.2 | NOK 292.4B | NOK 3,600.58 | 0.50% down | 42% up | ||
| 60 | NovartisNVS · Health Care | 29.0 | NOK 2.8T | NOK 1,483.20 | 2.08% down | 25% up | ||
| 61 | McKessonMCK · Health Care | 27.3 | NOK 1.19T | NOK 10,326.16 | 2.43% down | 28% up | ||
| 62 | QiagenQGEN · Health Care | 26.8 | NOK 99.8B | NOK 483.15 | 0.11% down | 9% up | ||
| 63 | LivaNovaLIVN · Health Care | 26.7 | NOK 50.1B | NOK 908.61 | 1.52% down | 77% up | ||
| 64 | Ensign GroupENSG · Health Care | 26.6 | NOK 101.7B | NOK 1,743.25 | 2.38% down | 2% up | ||
| 65 | Protagonist TherapeuticsPTGX · Health Care | 26.4 | NOK 79.5B | NOK 1,217.40 | 1.90% down | 51% up | ||
| 66 | ChemedCHE · Health Care | 26.4 | NOK 69.6B | NOK 5,371.44 | 0.67% up | 27% up | ||
| 67 | Zimmer Biomet HoldingsZBH · Health Care | 26.0 | NOK 190B | NOK 1,004.11 | 0.42% down | 16% up | ||
| 68 | Quest DiagnosticsDGX · Health Care | 25.8 | NOK 278.3B | NOK 2,529.77 | 0.18% down | 38% up | ||
| 69 | Koninklijke PhilipsPHG · Health Care | 25.6 | NOK 280.6B | NOK 287.08 | 1.33% down | 12% up | ||
| 70 | AmgenAMGN · Health Care | 25.6 | NOK 2.33T | NOK 4,303.36 | 0.66% down | 32% up | ||
| 71 | Lantheus HoldingsLNTH · Health Care | 25.4 | NOK 65.1B | NOK 996.01 | 0.05% up | 90% up | ||
| 72 | AstraZenecaAZN · Health Care | 24.8 | NOK 2.66T | NOK 1,712.99 | 1.81% down | 1% up | ||
| 73 | MedtronicMDT · Health Care | 24.8 | NOK 1.26T | NOK 984.49 | 0.15% up | 1% up | ||
| 74 | Concentra Group Holdings ParentCON · Health Care | 24.5 | NOK 50.9B | NOK 404.48 | 1.13% down | 116% up | ||
| 75 | PACS GroupPACS · Health Care | 24.4 | NOK 66.6B | NOK 419.56 | 7.15% down | 77% up | ||
| 76 | Align TechnologyALGN · Health Care | 23.5 | NOK 110.7B | NOK 1,570.11 | 1.88% down | 23% up | ||
| 77 | Neurocrine BiosciencesNBIX · Health Care | 23.4 | NOK 155.6B | NOK 1,537.22 | 3.29% down | 17% up | ||
| 78 | Halozyme TherapeuticsHALO · Health Care | 23.1 | NOK 102.9B | NOK 902.66 | 3.46% down | 39% up | ||
| 79 | Henry ScheinHSIC · Health Care | 23.1 | NOK 90.9B | NOK 822.73 | 1.62% down | 20% up | ||
| 80 | SanofiSNY · Health Care | 22.9 | NOK 1.08T | NOK 449.91 | 2.16% down | 4% down | ||
| 81 | Option Care HealthOPCH · Health Care | 22.9 | NOK 46.2B | NOK 308.60 | 0.28% down | 12% up | ||
| 82 | MSA SafetyMSA · Health Care | 22.8 | NOK 66.8B | NOK 1,734.22 | 0.14% up | 16% up | ||
| 83 | CenteneCNC · Health Care | 22.5 | NOK 316.7B | NOK 639.64 | 2.83% down | 94% up | ||
| 84 | InsuletPODD · Health Care | 22.4 | NOK 92.8B | NOK 1,337.54 | 2.09% down | 55% down | ||
| 85 | ResMedRMD · Health Care | 21.6 | NOK 325B | NOK 2,310.71 | 2.41% down | 1% down | ||
| 86 | United TherapeuticsUTHR · Health Care | 21.3 | NOK 234.1B | NOK 5,495.68 | 2.46% down | 22% up | ||
| 87 | Encompass HealthEHC · Health Care | 21.2 | NOK 126.9B | NOK 1,292.84 | 1.82% down | 20% up | ||
| 88 | Regeneron PharmaceuticalsREGN · Health Care | 20.7 | NOK 947.6B | NOK 9,160.38 | 0.73% down | 28% up | ||
| 89 | Cooper CompaniesCOO · Health Care | 20.7 | NOK 111.9B | NOK 588.65 | 0.72% down | 15% down | ||
| 90 | Smith & NephewSNN · Health Care | 20.4 | NOK 122.2B | NOK 292.35 | 1.20% down | 5% down | ||
| 91 | ExelixisEXEL · Health Care | 19.8 | NOK 157.5B | NOK 645.64 | 3.13% down | 63% up | ||
| 92 | CencoraCOR · Health Care | 19.1 | NOK 637.2B | NOK 3,338.93 | 1.78% down | 4% down | ||
| 93 | UnitedHealth GroupUNH · Health Care | 19.1 | NOK 2.92T | NOK 3,258.41 | 4.58% down | 12% up | ||
| 94 | Boston ScientificBSX · Health Care | 18.2 | NOK 611.2B | NOK 421.66 | 1.00% down | 55% down | ||
| 95 | GE HealthCare TechnologiesGEHC · Health Care | 17.4 | NOK 362.8B | NOK 802.33 | 1.73% down | 12% up | ||
| 96 | Globus MedicalGMED · Health Care | 17.1 | NOK 89.7B | NOK 676.82 | 1.67% down | 14% down | ||
| 97 | Ascendis PharmaASND · Health Care | 17.0 | NOK 165.3B | NOK 2,520.59 | 4.46% down | 29% up | ||
| 98 | GSKGSK · Health Care | 16.7 | NOK 939B | NOK 468.46 | 1.19% down | 5% up | ||
| 99 | Elevance HealthELV · Health Care | 16.7 | NOK 827.7B | NOK 3,831.00 | 2.07% down | 28% up | ||
| 100 | HCA HealthcareHCA · Health Care | 15.4 | NOK 944.1B | NOK 4,519.39 | 2.79% down | 0% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7595 NOK). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/E ratio?
Charles River Laboratories International (359), Takeda Pharmaceutical (306) and Waters (192) are the top three of the 115 health care companies ranked by P/E ratio as of 19 Nov 2026, 18:33 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of NOK 87.42T as of 19 Nov 2026, 18:33 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.